13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q3 2016. See the latest, Q2 2026 →
Reported value
$399.22B
+3.2% on the quarter before
Positions
2,174
286 new · 185 sold out
Top 10
15.5%
of the value
Est. gain
+$11.62B
on stocks held all quarter
Est. return
+3.3%
on those stocks since Q2 2016
Positions as of Sep 30, 2016, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2016. Striped tiles are options.
Largest buys
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Visa Inc.~$1.35BAdded · 0.3% → 0.6%+16,318,431 shares
- Mckesson Corp~$1.18BAdded · 0.7% → 0.9%+7,067,950 shares
- Ihs Markit Ltd~$1.11BNew · 0.0% → 0.3%+29,648,826 shares
- Philip Morris Intl Inc~$1.11BAdded · 0.4% → 0.6%+11,369,547 shares
- Netflix~$1.08BAdded · 0.0% → 0.3%+10,995,444 shares
- Apple~$901.1MAdded · 0.6% → 1.0%+7,971,116 shares
- Intel~$822.8MAdded · 0.8% → 1.2%+21,796,695 shares
- Xl Group Ltd~$634.7MNew · 0.0% → 0.2%+18,871,941 shares
- Kinder Morgan~$436.3MAdded · 0.0% → 0.1%+18,864,549 shares
- Hca Holdings Inc~$425.0MAdded · 0.5% → 0.5%+5,619,636 shares
Largest sells
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Merck & Co Inc~$1.57BCut · 2.6% → 2.4%−25,126,219 shares
- Wells Fargo & Co New~$1.07BCut · 1.6% → 1.2%−24,175,313 shares
- Oracle~$772.2MCut · 0.3% → 0.0%−19,657,815 shares
- Xl Group Plc~$606.6MSold out · 0.2% → 0.0%−18,210,309 shares
- Pioneer Nat Res Co~$573.1MCut · 0.5% → 0.5%−3,086,883 shares
- Cvs Health Corp~$542.8MCut · 0.6% → 0.4%−6,099,341 shares
- Baxter Intl Inc~$487.4MCut · 0.3% → 0.1%−10,239,697 shares
- Amgen Inc~$420.0MCut · 0.5% → 0.5%−2,517,556 shares
- Texas Instruments~$419.2MCut · 0.2% → 0.1%−5,972,653 shares
- Colgate Palmolive Co~$402.6MCut · 0.8% → 0.6%−5,430,592 shares
Holdings
As of Sep 30, 2016. Changes are in shares against Jun 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Co IncCOM · shares −14% · price +8.3% | 2.4% | $9.41B | +$723.9M | ||||||||
| MicrosoftCOM · shares −4.0% · price +12.6% | 2.0% | $7.91B | +$882.7M | ||||||||
| Bristol Myers Squibb CoCOM · shares +5.3% · price −26.7% | 1.8% | $7.36B | −$2.54B | ||||||||
| Unitedhealth Group IncCOM · shares −3.4% · price −0.8% | 1.8% | $7.12B | −$61.0M | ||||||||
| Medtronic PlcSHS · shares −3.0% · price −0.4% | 1.6% | $6.36B | −$27.3M | ||||||||
| Allergan PlcSHS · shares +1.1% · price −0.3% | 1.4% | $5.56B | −$18.6M | ||||||||
| Wells Fargo & Co NewCOM · shares −19% · price −6.4% | 1.2% | $4.66B | −$321.1M | ||||||||
| IntelCOM · shares +22% · price +15.1% | 1.2% | $4.59B | +$494.3M | ||||||||
| Johnson & JohnsonCOM · shares −2.0% · price −2.6% | 1.1% | $4.52B | −$121.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares −0.8% · price +7.2% | 1.1% | $4.52B | +$302.4M | ||||||||
| Exxon Mobil CorpCOM · shares +6.2% · price −6.9% | 1.1% | $4.46B | −$310.9M | ||||||||
| Chubb LimitedCOM · shares +0.7% · price −3.9% | 1.1% | $4.28B | −$171.3M | ||||||||
| Chevron Corp NewCOM · shares +2.6% · price −1.8% | 1.0% | $4.18B | −$75.6M | ||||||||
| AppleCOM · shares +31% · price +18.3% | 0.95% | $3.80B | +$448.0M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares +0.7% · price +10.7% | 0.95% | $3.78B | +$362.5M | ||||||||
| Mckesson CorpCOM · shares +47% · price −10.7% | 0.93% | $3.71B | −$302.1M | ||||||||
| AlphabetCAP STK CL A · shares −0.8% · price +14.3% | 0.91% | $3.65B | +$456.1M | ||||||||
| Eli LillyCOM · shares +4.2% · price +1.9% | 0.91% | $3.62B | +$65.4M | ||||||||
| CiscoCOM · shares −1.0% · price +10.6% | 0.90% | $3.60B | +$344.0M | ||||||||
| Honeywell TechnologiesCOM · shares −5.2% · price +0.2% | 0.89% | $3.54B | +$8.2M | ||||||||
| Comcast Corp NewCL A · shares −4.2% · price +1.8% | 0.85% | $3.39B | +$58.7M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −4.3% · price −1.8% | 0.83% | $3.31B | −$59.6M | ||||||||
| BlackRockCOM · shares +1.1% · price +5.8% | 0.82% | $3.27B | +$178.0M | ||||||||
| Verizon Communications IncCOM · shares −9.3% · price −6.9% | 0.81% | $3.24B | −$240.9M | ||||||||
| United Parcel Service IncCL B · shares +0.03% · price +1.5% | 0.81% | $3.23B | +$48.4M | ||||||||
| Total · 2,174 positions | 100% | $399.22B | +$11.62B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2016 to Q3 2016: 1,793 stocks held throughout, up $11.62B (+3.3%).
- Microsoft+$882.7M+13%
- Merck & Co Inc+$723.9M+8%
- Intel+$494.3M+15%
- Alphabet+$456.1M+14%
- Apple+$448.0M+18%
- Verizon Communications Inc−$240.9M−7%
- Mckesson Corp−$302.1M−11%
- Exxon Mobil Corp−$310.9M−7%
- Wells Fargo & Co New−$321.1M−6%
- Bristol Myers Squibb Co−$2.54B−27%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |